Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

1.

TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.

Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS.

Cytokine. 2007 Oct;40(1):1-16. Epub 2007 Nov 5. Review.

PMID:
17981048
[PubMed - indexed for MEDLINE]
2.

TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.

Dohi T, Borodovsky A, Wu P, Shearstone JR, Kawashima R, Runkel L, Rajman L, Dong X, Scott ML, Michaelson JS, Jakubowski A, Burkly LC.

Gastroenterology. 2009 Mar;136(3):912-23. doi: 10.1053/j.gastro.2008.11.017. Epub 2008 Nov 8.

PMID:
19109961
[PubMed - indexed for MEDLINE]
3.

Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.

Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C.

J Immunol. 2006 Feb 1;176(3):1889-98.

PMID:
16424220
[PubMed - indexed for MEDLINE]
Free Article
4.

TWEAK is a novel arthritogenic mediator.

Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, Su L, Tarilonte L, Crowell T, Rajman L, Runkel L, Scott M, Atkins GJ, Findlay DM, Zheng TS, Hess H.

J Immunol. 2006 Aug 15;177(4):2610-20.

PMID:
16888023
[PubMed - indexed for MEDLINE]
Free Article
5.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
[PubMed - indexed for MEDLINE]
6.

TWEAKing renal injury.

Sanz AB, Moreno JA, Sanchez-Nino MD, Ucero AC, Benito A, Santamaria B, Justo P, Izquierdo MC, Egido J, Blanco-Colio LM, Ortiz A.

Front Biosci. 2008 Jan 1;13:580-9. Review.

PMID:
17981571
[PubMed - indexed for MEDLINE]
7.

The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.

Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME.

J Biol Chem. 2005 Feb 4;280(5):3483-92. Epub 2004 Dec 16.

PMID:
15611130
[PubMed - indexed for MEDLINE]
Free Article
8.

TWEAK, a multifunctional cytokine in kidney injury.

Sanz AB, Sanchez-Niño MD, Ortiz A.

Kidney Int. 2011 Oct;80(7):708-18. doi: 10.1038/ki.2011.180. Epub 2011 Jun 22. Review.

PMID:
21697814
[PubMed - indexed for MEDLINE]
9.

TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.

Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.

Arthritis Res Ther. 2006;8(5):R146.

PMID:
16945157
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.

Michaelson JS, Burkly LC.

Results Probl Cell Differ. 2009;49:145-60. doi: 10.1007/400_2008_18. Review.

PMID:
19513634
[PubMed - indexed for MEDLINE]
11.

TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.

Burkly LC, Michaelson JS, Zheng TS.

Immunol Rev. 2011 Nov;244(1):99-114. doi: 10.1111/j.1600-065X.2011.01054.x. Review.

PMID:
22017434
[PubMed - indexed for MEDLINE]
12.

No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies.

Zheng TS, Burkly LC.

J Leukoc Biol. 2008 Aug;84(2):338-47. doi: 10.1189/jlb.0308165. Epub 2008 May 15. Review. Erratum in: J Leukoc Biol. 2011 Sep;90(3):635.

PMID:
18483204
[PubMed - indexed for MEDLINE]
Free Article
13.

Cytokine cooperation in renal tubular cell injury: the role of TWEAK.

Justo P, Sanz AB, Sanchez-Niño MD, Winkles JA, Lorz C, Egido J, Ortiz A.

Kidney Int. 2006 Nov;70(10):1750-8. Epub 2006 Sep 27.

PMID:
17003819
[PubMed - indexed for MEDLINE]
14.

Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).

Shui Y, Guan ZB, Zhang SQ.

Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):396-402. doi: 10.1016/j.vetimm.2008.08.005. Epub 2008 Aug 23.

PMID:
18817982
[PubMed - indexed for MEDLINE]
15.

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H.

J Immunol. 2003 Jan 1;170(1):341-8.

PMID:
12496418
[PubMed - indexed for MEDLINE]
Free Article
16.

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.

Blanco-Colio LM, Martín-Ventura JL, Munoz-Garcia B, Moreno JA, Meilhac O, Ortiz A, Egido J.

Front Biosci. 2007 May 1;12:3648-55. Review.

PMID:
17485328
[PubMed - indexed for MEDLINE]
17.

Considering TWEAK as a target for therapy in renal and vascular injury.

Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, Egido J, Blanco-Colio LM.

Cytokine Growth Factor Rev. 2009 Jun;20(3):251-8. doi: 10.1016/j.cytogfr.2009.05.002. Epub 2009 May 30. Review.

PMID:
19482507
[PubMed - indexed for MEDLINE]
18.

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.

Campbell S, Michaelson J, Burkly L, Putterman C.

Front Biosci. 2004 Sep 1;9:2273-84. Review.

PMID:
15353286
[PubMed - indexed for MEDLINE]
19.

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.

Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2061-8. doi: 10.1161/ATVBAHA.109.194852. Epub 2009 Sep 24.

PMID:
19778942
[PubMed - indexed for MEDLINE]
Free Article
20.

Tweak and FN14 in central nervous system health and disease.

Yepes M.

Front Biosci. 2007 May 1;12:2772-81. Review.

PMID:
17485258
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk